000 01395 a2200445 4500
005 20250518005110.0
264 0 _c20190416
008 201904s 0 0 eng d
022 _a1750-1172
024 7 _a10.1186/s13023-018-0927-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSzegedi, Márta
245 0 0 _aThe European challenges of funding orphan medicinal products.
_h[electronic resource]
260 _bOrphanet journal of rare diseases
_c11 2018
300 _a184 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aDrug Costs
650 0 4 _aEurope
650 0 4 _aEuropean Union
650 0 4 _aHealth Expenditures
650 0 4 _aHumans
650 0 4 _aOrphan Drug Production
_xeconomics
650 0 4 _aRare Diseases
700 1 _aZelei, Tamás
700 1 _aArickx, Francis
700 1 _aBucsics, Anna
700 1 _aCohn-Zanchetta, Emanuelle
700 1 _aFürst, Jurij
700 1 _aKamusheva, Maria
700 1 _aKawalec, Pawel
700 1 _aPetrova, Guenka
700 1 _aSlaby, Juraj
700 1 _aStawowczyk, Ewa
700 1 _aVocelka, Milan
700 1 _aZechmeister-Koss, Ingrid
700 1 _aKaló, Zoltán
700 1 _aMolnár, Mária Judit
773 0 _tOrphanet journal of rare diseases
_gvol. 13
_gno. 1
_gp. 184
856 4 0 _uhttps://doi.org/10.1186/s13023-018-0927-y
_zAvailable from publisher's website
999 _c29012719
_d29012719